Alimentary pharmacology & therapeutics
-
Aliment. Pharmacol. Ther. · Aug 2008
Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Faecal occult blood testing (FOBT), flexible sigmoidoscopy (FS) and colonoscopy are recommended for subjects above 50 years of age for screening for colorectal cancer (CRC). ⋯ FOBT is cost-effective compared to FS or colonoscopy for CRC screening in average-risk individuals aged from 50 to 80 years.